HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Clinical Nomogram to Predict Major Adverse Cardiac Events in Acute Myocardial Infarction Patients within 1 Year of Percutaneous Coronary Intervention.

Abstract
The purpose of this study was to summarize the clinical characteristics and risk factors of major adverse cardiovascular events (MACEs) in patients who had had acute myocardial infarction (AMI) within 1 year of percutaneous coronary intervention (PCI). A total of 421 AMI patients who were treated with PCI and experienced MACEs within 1 year of their admission were included in this retrospective study. In addition, patients were matched for age, sex, and presentation with 561 patients after AMI who had not had MACEs. The clinical characteristics and risk factors for MACEs within 1 year in AMI patients were investigated, to develop a nomogram for MACEs based on univariate and multivariate analyses. The C statistic was used to assess the discriminative performance of the nomogram. In addition, calibration curve and decision curve analyses were conducted to validate the calibration performance and utility, respectively, of the nomogram. After univariate and multivariate analyses, a nomogram was constructed based on age (odds ratio (OR): 1.030; 95% confidence interval (CI): 1.014-1.047), diabetes mellitus (OR: 1.667; 95% CI: 1.151-2.415), low-density lipoprotein cholesterol (OR: 1.332; 95% CI: 1.134-1.565), uric acid (OR: 1.003; 95% CI: 1.001-1.005), lipoprotein (a) (OR: 1.003; 95% CI: 1.002-1.003), left ventricular ejection fraction (OR: 0.929; 95% CI: 0.905-0.954), Syntax score (OR: 1.075; 95% CI: 1.053-1.097), and hypersensitive troponin T (OR: 1.002; 95% CI: 1.002-1.003). The C statistic was 0.814. The calibration curve showed good concordance of the nomogram, while decision curve analysis demonstrated satisfactory positive net benefits. We developed a convenient, practical, and effective prediction model for predicting MACEs in AMI patients within 1 year of PCI. To ensure generalizability, this model requires external validation.
AuthorsDefeng Pan, Shengjue Xiao, Yue Hu, Qinyuan Pan, Qi Wu, Xiaotong Wang, Qiaozhi Liu, Ailin Liu, Jie Liu, Hong Zhu, Yufei Zhou
JournalCardiovascular therapeutics (Cardiovasc Ther) Vol. 2021 Pg. 3758320 ( 2021) ISSN: 1755-5922 [Electronic] England
PMID34987604 (Publication Type: Journal Article)
CopyrightCopyright © 2021 Defeng Pan et al.
Topics
  • Humans
  • Myocardial Infarction (diagnosis, therapy)
  • Nomograms
  • Percutaneous Coronary Intervention (adverse effects)
  • Retrospective Studies
  • Risk Factors
  • Stroke Volume
  • Ventricular Function, Left

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: